Meta-analysis suggests about 8,500 daily steps may help limit weight regain after dieting

An international meta-analysis slated for presentation at the European Congress on Obesity (ECO 2026) in Istanbul, Turkey (May 12–15) suggests that people who increase their walking to roughly 8,500 steps a day during a weight-loss program and sustain similar levels afterward may be less likely to regain weight.

A systematic review and meta-analysis led by Professor Marwan El Ghoch of the University of Modena and Reggio Emilia assessed randomized controlled trials examining step-count-based lifestyle programs and weight outcomes.

Researchers screened 18 trials and included 14 randomized controlled trials comprising 3,758 adults in the final meta-analysis. Across the trials, participants in lifestyle modification programs combined dietary guidance with recommendations to walk more and track daily steps.

By the end of the weight-loss phase (average duration 7.9 months), people in the lifestyle modification programs increased their walking to an average of 8,454 steps per day and lost an average of 4.39% of their body weight (about 4 kg, as reported in the conference materials).

By the end of the maintenance phase (average duration 10.3 months), participants were still averaging 8,241 steps per day and, on average, maintained most of their loss, with an average long-term weight loss of 3.28% (about 3 kg).

The analysis also reported that higher step counts were associated with less weight regain over time, while increased walking was not linked to greater weight loss during the initial dieting period. The researchers described increasing walking to around 8,500 steps per day as a practical strategy to support weight-loss maintenance.

Mga Kaugnay na Artikulo

Realistic illustration contrasting social stigma: neutral for overweight, positive for exercise weight loss, negative for Ozempic users.
Larawang ginawa ng AI

Study finds people who use Ozempic-like drugs for weight loss face added stigma

Iniulat ng AI Larawang ginawa ng AI Fact checked

People who lose weight using GLP-1 medications such as Ozempic and Wegovy may be judged more negatively than those who lose weight through diet and exercise — and even more negatively than people who do not lose weight at all — according to a new study led by Rice University psychologist Erin Standen.

Just a few minutes of activity that leaves people out of breath each day was associated with substantially lower risks of developing eight major diseases and of dying over about seven years in a study of roughly 96,000 UK Biobank participants who wore wrist accelerometers for a week. The research, published March 30, 2026 in the European Heart Journal, suggests that how intensely people move may matter alongside how much they move.

Iniulat ng AI

A new Cochrane review of 22 clinical trials shows that intermittent fasting does not lead to greater weight loss than standard diet advice for overweight or obese adults. The analysis, involving nearly 2,000 participants, challenges the popularity of fasting methods amid rising global obesity rates. Researchers emphasize the need for more long-term studies and personalized approaches.

A new study from Northwestern Medicine indicates that stopping eating three hours before bed and extending overnight fasting can improve blood pressure, heart rate, and blood sugar control without reducing calorie intake. Participants aligned their eating with natural sleep cycles, leading to measurable cardiometabolic benefits. The research highlights the importance of meal timing relative to sleep.

Iniulat ng AI

A comprehensive review of global research indicates that exercise, particularly aerobic activities, can significantly reduce symptoms of depression and anxiety. The analysis, covering tens of thousands of participants aged 10 to 90, shows exercise often matches or surpasses medication and talk therapy in effectiveness. Benefits were observed across all age groups and sexes, with supervised or group settings providing the greatest improvements.

Gumagamit ng cookies ang website na ito

Gumagamit kami ng cookies para sa analytics upang mapabuti ang aming site. Basahin ang aming patakaran sa privacy para sa higit pang impormasyon.
Tanggihan